3 Genius Artificial Intelligence (AI) Stocks You'll Regret Not Buying Now

Nvidia is expected to deliver ~70% revenue growth this fiscal year and trades at ~22x forward earnings (near the S&P's ~21x), implying the market discounts continued rapid growth; Broadcom projects its custom AI chip business will generate $100B+ by end-2027 and reported $8.4B in AI semiconductor revenue last quarter (up 106% YoY). Microsoft’s valuation is described as near decade-low P/E levels, presenting a buying opportunity per the author. Recommendation: the author recommends MSFT, NVDA and AVGO as buys based on persistent AI data-center demand and Broadcom's aggressive guidance, though the piece is opinion-driven and likely to have modest direct market impact.

Analysis

Winners are not just the headline chip designers — hyperscalers and cloud brokers that secure bespoke silicon deals will see structural OPEX/CapEx improvements that change procurement math. Expect procurement teams to push a 2-4 quarter RFP cycle toward custom ASICs driven by unit-cost per inference and datacenter TCO, which will increase negotiating leverage for large cloud buyers and compress resale opportunities for traditional OEM blade vendors.

Supply-side effects will matter more than single-quarter guidance: TSMC/ASML capacity allocation and back-end testing bottlenecks will create windows where design winners convert orders into margin disproportionately. That creates timing dispersion — calendar-year 2026 could be the trough for non-winning suppliers while 2027–2028 concentrates the wins; revenue shift rates of 20–30% into winners within 12–24 months are realistic based on past ASIC adoption curves.

Key risks are cadence and architectural obsolescence. A single generational leap in model sparsity or a lightweight inference architecture could materially reduce GPU-hours per model, collapsing demand elasticity; conversely, sustained large-model training budgets would keep demand high but concentrate counterparty risk into a few hyperscalers. Short-term catalysts to watch are large multi-year customer disclosures, TSMC capacity announcements, and export-control moves — any of which can reprice winners within days but play out in realized revenues over quarters.

Key Decisions for Investors

• NVDA long/market‑neutral option: Buy NVDA 12–18 month LEAPS call (allocate 1.5–3% portfolio) and hedge market beta by buying a 6–12 month MSFT 1:1 put spread (net cost ~small premium). Rationale: captures asymmetric upside from design-win re-rating while keeping downside limited to option premium; target 2.5x premium if NVDA sustains AI spend, stop/trim if NVDA falls 30% from entry.
• AVGO growth capture: Buy AVGO shares or 9–12 month call spread (allocate 2–4%). Rationale: asymmetric upside if custom-chip bookings accelerate into multi-year contracts; set a conservative target of +30–50% over 12 months with downside risk of -20–25% on missed bookings or guide-downs — consider selling short-dated calls to finance if you need to lower basis.
• Relative-value pair: Long NVDA (10–12 month call spread) / Short MSFT (6–9 month put spread) sized 0.6:1 by notional to remove market beta while expressing concentration into accelerators. Timeframe: 6–12 months. Risk/reward: if AI capex re-allocates to accelerators, expect asymmetric payoff >2:1; if broader market sells off, hedge reduces portfolio drawdown.
• Contrarian asymmetric: Buy INTC 12–18 month OTM call spread (small allocation <1.5%). Rationale: low-cost ticket on Intel reclaiming accelerator relevancy via differentiated IP or packaging wins; capped loss = premium, upside if Intel lands a hyperscaler design win or benefits from export-control-driven demand shifts.